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ABSTRACT
Dyspnea is the main symptom perceived by patients affected
by chronic respiratory diseases. It derives from a complex
interaction of signals arising in the central nervous system,
which is connected through afferent pathway receptors to
the peripheral respiratory system (airways, lung, and thorax).
Notwithstanding the mechanism that generates the stimulus
is always the same, the sensation of dyspnea is often
described with different verbal descriptors: these descriptors,
or linguistic ‘clusters’, are clearly influenced by socio-individ-
ual factors related to the patient. These factors can play an
important role in identifying the etiopathogenesis of the
underlying cardiopulmonary disease causing dyspnea.
The main goal of rehabilitation is to improve dyspnea; hence,
quantifying dyspnea through specific tools (scales) is essen-
tial in order to describe the level of chronic disability and to
assess eventual changes after intervention. Improvements,
even if modest, are likely to determine clinically relevant
changes (minimal clinically important difference, MCID) in
patients.
Currently there exist a large number of scales to classify and
characterize dyspnea: the most frequently used in everyday
clinical practice are the clinical scales (e.g. MRC or BDI/TDI, in
which information is obtained directly from the patients
through interview) and psychophysical scales (such as the
Borg scale or VAS, which assess symptom intensity in
response to a specific stimulus, e.g. exercise).
It is also possible to assess the individual’s dyspnea in rela-
tion to specific situations, e.g. chronic dyspnea (with scales
that classify patients according to different levels of respira-
tory disability); exertional dyspnea (with tools that can
measure the level of dyspnea in response to a physical stim-
ulus); and transitional (or ‘follow up’) dyspnea (with scales
that measure the effect in time of a treatment intervention,
such as rehabilitation). 
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RIASSUNTO 
La dispnea è il principale sintomo riferito da pazienti con pa-
tologie croniche dell’apparato respiratorio e rappresenta il
prodotto dell’interazione complessa di numerosi segnali che
nascono dal sistema nervoso centrale, il quale riceve afferen-
ze da recettori delle strutture respiratorie periferiche (alte vie
aeree, polmoni e torace).
Pur avendo un unico meccanismo di generazione dello stimo-
lo, la sensazione dispnoica è spesso percepita e descritta dai
pazienti in termini differenti: i descrittori verbali, che defini-
scono un linguaggio in “cluster” specifici, sono influenzati da
molteplici fattori socio-individuali legati al paziente. Possono
svolgere un ruolo determinante nell’identificazione etiopato-
genetica della patologia cardio-polmonare causale.
Il miglioramento della dispnea rappresenta il principale obiet-
tivo della riabilitazione e la quantificazione di essa, attraverso
strumenti specifici (scale), assume un elemento indispensabi-
le per la definizione del grado di disabilità cronica respiratoria
e dell’eventuale miglioramento clinico-sintomatologico post
intervento. Tali miglioramenti, anche se di modeste entità,
possono comunque produrre variazioni clinicamente rilevanti
(MCID).
Al momento esistono numerose modalità di classificazione e
caratterizzazione delle scale della dispnea: nella pratica quo-
tidiana si distinguono scale cliniche (rilevate dal colloquio di-
retto dal paziente come le scale MRC e BDI/TDI) e psicofisiche
(quali Borg e VAS che valutano l’intensità del sintomo come
risposta a uno specifico stimolo, ad esempio l’esercizio fisico).
È inoltre possibile distinguere momenti differenti di rilevazio-
ne della dispnea: in particolare esiste una valutazione della di-
spnea cronica (misurata attraverso scale idonee alla stratifi-
cazione di pazienti con disabilità respiratorie differenti), della
dispnea da sforzo (con strumenti utili alla determinazione
della risposta dispnoica a uno stimolo fisico) e della dispnea
transizionale o del follow up (attraverso misure che rappre-
sentano gli effetti a distanza di un intervento terapeutico, ad
esempio la riabilitazione). 
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Dyspnea, the main symptom present in patients
with chronic respiratory diseases, is a general term
that characterizes a subjective sensation of difficulty
in breathing [1]. In clinical practice, the quantita-
tive assessment of this symptom can be useful for
defining the patient’s real level of respiratory dis-
ability; applied in pulmonary rehabilitation (PR) as
an outcome measure it is useful to establish the effi-
cacy - in terms of improvement of symptoms – of
the intervention carried out, particularly in relation to
programs that include general exercise training [2]. 
THE LANGUAGE OF DYSPNEA 
Although it is an aspecific symptom generated
through a common mechanism, dyspnea consists of
qualitatively distinct sensations that vary in intensity
and that, influencing the patient’s personal percep-
tion, are closely dependent upon multiple personal
factors such as socio-economic status, linguistic
aspects, affective-cultural components and previous
personal experience [3-5]. 
Hence, since dyspnea is perceived and described in
different terms and modes, it is retained that there
exist a series of ‘descriptors’ [1] indispensable for
the expression of a specific language linked to effi-
cacy of intervention and to defining the underlying
pathophysiological causal mechanisms [4-6].
Regarding these multiple distinct sensations, diverse
verbal descriptors have been grouped into distinc-
tive “clusters” that have a high discriminating
capacity [4-6]: a recent study [7], in fact, claims that
the language used to describe the sensation of dys-
nea is capable of differentiating and thus classify-
ing, through specific descriptors, individuals affect-
ed by chronic obstructive pulmonary diseases
(COPD). 
In the field of cardiopulmonary disease, the five
descriptive clusters in the language of dyspnea most
frequently selected are: ‘chest tightness’, ‘increased
effort of breathing’, ‘unsatisfied inspiratory effort’,
‘rapid or superficial breathing’ and ‘breathlessness’
[1].
The sensation of ‘chest tightness’, frequently report-
ed by asthmatic patients during acute bronchial
obstruction, may derive from the stimulation of the
pulmonary sensory receptors through vagal and
autonomous pathways [8]: these slow adapting
receptors, excited by the contraction of the airway
muscle fibers, together with receptors from irritation
(fast adapting) and C fibers could respond to the
local airways inflammation [8]. Supporting this
hypothesis would be the clinical observation that
anesthesia of the airways with lidocaine induces the
chest constriction associated to bronchial obstruc-
tion induced by histamine [9].
The cluster ‘increased work or effort of breathing’
includes instead descriptors often selected in condi-
tions of increased mechanical load, such as occurs
in COPD and in interstitial or neuromuscular dis-
eases. The work/effort element, inadequate due to
respiratory muscle fatigue or such as occurs during
physical exercise, provokes an increase of the
‘corollary discharge’ [10] (central motor command
to the sensitive cortex through small, highly local-
ized interneurones in the central nervous system,
that function as sensory receptors). The intensity of
the command, alone or in combination with the
force generation and contraction of the respiratory
muscles, is appreciated at the conscious level as
‘difficulty of breathing’ [11].
The respiratory muscles are nevertheless important
in the experience of dyspnea. ‘Unsatisfied inspirato-
ry effort’ is a cluster that refers to conditions in
which there is a disparity between central respiratory
output and mechanical response of the respiratory
system and it is considered to play a fundamental
role in the increased perception of dyspnea during
physical exercise in patients affected by COPD and
interstitial diseases [12-14]. In COPD, in fact,
dynamic hyperinflation during exercise contributes
most to provoke mechanical limitations of the chest
cage with a consequent increase of end-expiration
lung volume and limitation to the increase of both
flow volume and inspiratory capacity, responsible
in their turn for the sensation of ‘difficulty of breath-
ing in’ [12,15]. Reduced lung volumes and
increased central respiratory drive explain the
imbalance between increased central stimulus and
probable reduction of the peripheral feedback
between lung and rib cage [12,13]. The perception
of this disparity is possible since the corollary dis-
charge is modulated by a series of peripheral
mechanoreceptors that provide precise information
on the inspiratory muscles, on variations of flow-
volume produced and on the calibre of the airways
[11]. The disparity between this sensory feedback
and the degree of effort in breathing is what under-
lies a pathogenetic mechanism of dyspnea recently
proposed and defined as ‘neuroventilatory dissocia-
tion’ [12].
‘Rapid or shallow breathing’ is the respiratory clus-
ter referred as a transitory experience by normal
subjects during intense physical exercise or in the
presence of external chest restriction [4-6]; it char-
acterizes, in pathological terms, the response to
exercise of patients with interstitial diseases [14].
The increased central drive provokes an increased
breathing rate due to the reduced lung elastance:
this mechanism would appear to be mediated by
vagal receptors [16].
‘Breathlessness’, ‘lack of breath’ or ‘a sense of suf-
focation’ is a cluster that tends often to be associat-
ed to patients affected by congestive heart failure or
other pathophysiological conditions (pregnancy,
physical exercise, COPD). This dyspnea cluster is
characterized by an increased respiratory drive,
usually associated to increased ventilation [4]; it is
in any case probable that the increased “impuse to
breathe” comes directly from chemoreceptor affer-
ents and from an increased alveolar partial pressure
of carbon dioxide in the blood (PaCO2) [17]. In






























0 directly on the activation of the respiratory muscles or
on an increase of pulmonary ventilation: in patients
with a high cervical lesion on mechanical ventilation,
in fact, the addition of PaCO2 to the inspired gas pro-
duces a “hard to breathe” sensation characterized by
the “hunger for air” notwithstanding that ventilation is
maintained at a constant level [17]. 
DYSPNEA SCALES AND THEIR CLINICAL
SIGNIFICANCE 
In patients with chronic respiratory disability
improving exercise tolerance and the correlated
symptom of dyspnea constitutes the main goal of
rehabilitation. Assessment of dyspnea, thus, is
essential as an outcome marker of efficacy.
Moreover, in patients admitted to PR programs, the
assessment of dyspnea during exercise makes it
possible to tailor the training program to the
patient’s needs and capacities [18-19].
In reality, the difficulty of “measuring” a symptom
implicates, as already stated, the need to be able to
translate a subjective personal experience into a
numeric parameter. Furthermore, the symptom of
dyspnea represents a single and specific dimension
of respiratory disease, measurable only through
direct assessment: it is not, in fact, possible to eval-
uate it indirectly from other instrumental examina-
tions such as, for example, lung function tests [20].
The use of specific tools (assessment scales) to
quantify dyspnea thus permits to classify the severi-
ty of the symptom and the distress generated there-
by, and to monitor it over time (Table I).
Numerous clinical studies have thus utilized dysp-
nea – through variations of the assessment scales –
as a clinical outcome useful for evaluating the
response to muscle training interventions: these
changes in symptoms, even if of a modest size, can
produce clinically significant variations in the
patients (minimally clinically important difference,
MCID) (Figure 1) [2]. A statistical criterion useful for
analyzing the sensitivity of the dyspnea assessment
tool in terms of the effect of rehabilitation can be
obtained by determining the “Effect Size” (ES),
mathematically calculable as the variation of the
score after a rehabilitation intervention divided by
the standard deviation of the baseline value [21]: a
greater variation of dyspnea linked to PR evidences
a high value of ES.
At present, there exist numerous modes for classify-
ing and characterizing the tools used to assess dys-
pnea. Substantially, one can distinguish “discrimi-
native” scales (that differentiate study populations
based on the level of perceived dyspnea) from
“evaluative” tools (that identify variations with
respect to a baseline condition). In addition one can
distinguish “categorical” scales, that quantify the
symptom according to categories (mild, moderate
and severe dyspnea, as in the Borg Scale), from
“analogical” scales (e.g. the Visual Analogue Scale
or VAS, where the determination of the severity of
dyspnea is of an analogical type). Furthermore,
depending on the relationship that exists between
assessment scale and the symptom it is possible to
distinguish “direct” scales (that investigate directly
the level of the symptom perceived) and “indirect”
(that evaluate, for example, the activities that dysp-
nea limits in daily life). Finally, based on whether
the assessment tool identifies a single or several
dimensions of the sensation of dyspnea it is possible
to distinguish “unidimensional” scales (which con-
sider only the type of activity that provokes the dysp-
nea) from “multidimensional” scales (which also take
other aspects into account, such as functional impair-
ment, the size of the task that evokes dyspnea and the
degree of exertion associated to the sensation).
In daily clinical practice there exist thus “clinical”
scales (completed by the patient during the medical
interview) and “psycho-physical” scales (that evalu-
ate the intensity of the symptom as a response to a
stimulus, such as physical exercise or pharmacolog-
ically induced bronchodilatation). 
Clinical scales
Medical Research Council (MRC) scale
Defined in 1959 by Fletcher et al. [22] the MRC
TABLE I: INSTRUMENTS FOR MEASURING DYSPNEA AND THEIR FIELD OF APPLICATION IN CLINICAL PRACTICE 
AND REHABILITATION   
Dyspnea assessment
Measurement tool chronic at exercise at follow up
MRC ++ - ++
BDI ++ - ++
TDI - ++ +
Modified Borg Scale - +++ -
VAS - ++ -
LCADL ++ - ++
PFSDQ ++ - ++
OCD - + -
Definition of abbreviations: BDI, Baseline Dyspnea Index; LCADL, London Chest Activity of Daily Living Scale; MRC, Medical Research Council;
OCD, Oxygen Cost Diagram; PFSDQ, Pulmonary Functional Status and Dyspnea Questionnaire; TDI, Transitional Dyspnea Index; VAS, Visual
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scale, the first clinical scale for the determination of
dyspnea, is a 5-point scale based on the sensation
of breathing difficulty experienced by the patient
during daily life activities (Table II). Patients, reading
the scale, are invited to recognize their own level of
respiratory fatigue or, as is more often the case, the
MRC can be directly administered.
Level 0 represents the lowest level of dyspnea
impairment perceived, level 4 the greatest dyspnea
impairment. While for level 0 and 1 the MRC is
considered as a symptomatic scale, in that the effort
that produces the symptom is defined, levels 2, 3
and 4 yield indications concerning personal capac-
ities and social impact (see Table II). As regards the
activity theshold able to evoke the sensation of dys-
pnea, the MRC is not able to evaluate the mode of
performing the task, nor the effort or time required
to complete it.
Hence, while it is widely used in the field of reha-
bilitation, mostly as a discriminative tool to charac-
terize study populations or stratify patients with
diverse lung function impairment [23], the use of
the MRC scale, due to the limited number of levels
present, may not be specific enough to detect mod-
erate changes. Variations of 1 point in the scale nev-
ertheless signify a perceived clinical improvement
[24].
Baseline Dyspnea Index (BDI) - Transitional
Dyspnea Index (TDI)
These two tools [25] are often used in rehabilitation
both as a measure of treatment outcome and to
assess daily living activities (see below). While the
BDI, as its name indicates, constitutes the initial
baseline assessment (discriminative tool), the TDI is
administered at a certain point after the rehabilita-
tion intervention has been carried out and it pro-
vides a measure of change with respect to the base-
line value. 
The unique feature of the BDI and TDI is that they
are composed of three categories (functional
impairment, magnitude of task and magnitude of
effort) that are useful for quantifying the limitation
due to dyspnea or the patient’s capacities that have
been impaired [25].
In the BDI each of the three categories has 5 levels
of symptom severity from 0 to 4 where 0 corre-
sponds to the most severe level: summing the scores
for each category, a lower total score indicates a
worse clinical condition (12 is the maximum possi-
ble score which corresponds to the least physical
limitation the patient can experience). The scale can
be administered informally by the doctor, nurse or
physiotherapist during the patient’s medical inter-
view and takes from 4 to 5 minutes to complete:
recently, a computerized version of the BDI has
been introduced in order to compare the total
scores obtained by different interviewers. 
In the area of ‘functional impairment’ (due to respi-
ratory disease), functional loss is evaluated in the
sphere of both daily living and occupational activi-
ties, which are often completely suspended.
‘Magnitude of task’ on the other hand assesses what
daily living tasks can provoke dyspnea, presenting
activities of increasing intensity with 5 available
response levels, 0 indicating always the greatest
degree of impairment (dyspnea at rest). Finally,
‘magnitude of effort’ evaluates specifically how
much effort needs to be sustained by the patient to
evoke dyspnea. This last aspect of the BDI is per-
haps the most singular in that it differentiates
patients who, while performing the same activities,
sustain efforts that are extremely diverse; the vari-
able “time needed to perform the activity” is also
explored together with the type of activity (more or
less strenuous).
Concerning the reliability of the BDI, several reports
have shown a good correlation between the BDI
total score and follow up assessments [26], good
inter-observer agreement [27] and good correlation
with total scores of other dyspnea scales [28,29].
Regarding use of the TDI, in order to explore with
respect to the baseline condition any functional
changes (including type and degree) it is necessary





































FIGURE 1: DYSPNEA MEASUREMENT TOOLS AND RELATIVE
CHANGES (POST-REHABILITATION) ACCORDING TO THE MCID
Definition of abbreviations: MCID, minimal clinically important 
difference; MRC, Medical Research Council; TDI, Transitional Dyspnea
Index ; VAS, Visual Analogue Scale.
TABLE II: MODIFIED MEDICAL RESEARCH COUNCIL (MRC)
SCALE   
0. I only get breathless with strenuous exercise
1. I get short of breath when hurrying on the level or walking up a
slight hill
2. I walk slower than people of the same age on the level because
of breathlessness or have to stop for breath when walking 
at my own pace on the level
3. I stop for breath after walking about 100 yards or after a few 
minutes on the level 
































0 remind the patient about the comments and choices
made during the initial interview. The patient
accordingly can choose the score 0 (no change) or
report a slight, moderate or marked change, worse
or improved with respect to baseline (3 levels above
or below zero) and this gives the scale great sensi-
tivity in determining changes in dyspnea. The scores
of the 3 categories are thus summed to obtain the
total score (variation) of the TDI which ranges
between - 9 and + 9.
Used in studies with COPD patients in clinically
stable condition, the TDI has shown to be sensitive
in measuring changes in dyspnea after use of phar-
macological drugs (e.g. tiotropium) [30] and in
measuring the progressive decline in lung function
[31]: variations of + 1 represent the threshold of
MCID at which the patient can perceive an
improvement of dyspnea (from BDI) [32]. However,
in the rehabilitation of COPD patients, use of the
TDI to assess outcome with respect to muscle train-
ing has shown this scale to be not particularly ade-
quate or sensitive to perceived improvement in dys-
pnea [33].
Psychophysical scales
Psychophyscial evaluation is a branch of psycholo-
gy that studies the laws that regulate the perception
of sensations in response to variations of stimulus.
Experimental studies of Stevens [34] in 1957 made
it possible to quantify perceptions by means of
methods and techniques regarding the estimation of
magnitude (the subject attributes a numerical score
to a workload added) and the reproduction of mag-
nitudes (the subject increases or reduces the stimu-
lus until the sensation is equal to a multiple or frac-
tion, as requested, of the baseline stimulus). In this
type of scale an absolute zero can be identified
(absense of perception of the symptom) and the
intervals in the score are equidistant. 
The psychophysical approach has made an impor-
tant contribution to the quantification of dyspnea,
in particular to dyspnea arising during physical
exercise and which can be evaluated by means of
laboratory tests (cardiopulmonary exercise test,
CPX) or field tests (6-min walking test, 6MWT).
Gunnar Borg in the ’70s, building on these premises,
elaborated a categorical scale, the Rating of Perceived
Exertion (RPE) [35], and the subsequent modified ver-
sion of the 10 Category-Ratio (CR 10) [36], both used
to assess the sensation of exertional dyspnea and
fatigue perceived during physical activity.
From the methodological point of view, however,
the Borg scales require particular care and attention
in their administration. The operator must a priori
evaluate the patient’s emotive disposition (since
patients can over- or under-estimate the perception
and quantification of the symptom) in order to be
certain that they have understood all the informa-
tion required to complete the scale and also that the
score they give to the symptom as they perceive it
regards “their sensation”, i.e. it will not be judged
or corrected. 
Rating of Perceived Exertion (RPE)
The RPE [35] is a categorical scale with verbal
descriptors (termed anchors) associated to a score
that rates the perceived level of exertion. The author
designed this dyspnea scale to overcome the limits
of comparing scores between different subjects: for
the same numerical score attributed to a sensation,
in fact, one cannot be sure that for two different
subjects the sensation is the same, and it is thus not
possible to compare scores across subjects. 
The verbal anchors thus create categories of sensa-
tion with which subjects can easily identify: “mod-
erate intensity” is placed at the center of the scale,
“strong” and “weak” symmetrically at the two ends
of the scale.
The principle of the scale - composed of 15 levels,
from 6 to 20 - is based on the notion that during
physical exercise a close correlation exists between
heart rate (HR) and workload: the scores of the RPE
have in fact been translated from values of HR dur-
ing exercise tests in a normal subject, where the
score 6 corresponds to 60 beats/min (medium rest-
ing HR) and the score 20 to the other extreme, i.e.
200 beats/min (considered as the maximum HR
attainable at exercise peak).
10 Category-Ratio (CR 10)
The CR 10 [36] is a categorical scale with a score
from 0 to 10, where 0 (as a measure of dyspnea)
corresponds to the sensation of normal breathing
(absence of dyspnea) and 10 corresponds to the
subject’s maximum possible sensation of dyspnea.
Also with this assessment tool the reference values
are always linked to verbal anchors, chosen from
commonly used terms, to facilitate the evaluation
and recall the sensation to the patient’s mind.
Above the value of 10 it is possible for the patient
to give a higher score, if they wish: this allows
patients to connotate with still greater precision
their own sensation (it is thus an open scale).
The version of the CR 10 that is usually adminis-
tered in respiratory patients is the version modified
by Mahler and Horowitz in 1994 [37] known as the
“Modified Borg Scale” (Table III) which uses specif-
ic descriptors of dyspnea. In the field of rehabilita-
tion, the modified Borg scale is widely used as an
instrument to prescribe workload during muscle
training sessions [18], and the clinical significance
of the rehabilitation outcome (in terms of perceived
dyspnea during physical exercise) has been validat-
ed [38]. Now, since the perception of exercise
induced dyspnea depends on the stimulus to which
the patient has been subjected, the evaluation by
means of the Borg scale should ideally be carried
out at the same workload.
Numerous studies in COPD patients have used this
scale as an outcome measure [39-41]. In reference
to CPX, for the measurement of dyspnea in muscle
training pre- and post- intervention, variations of 
-1.8 units (ES = 1.0) [39] and -2 units (ES=1.5) [41]
have been documented in iso-workload assess-
ments at incremental CPX, while changes of -1.6
units (ES = 0.8) have been reported in iso-time eval-
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Concerning use of the 6MWT as a stimulus test for
dyspnea in COPD patients on oxygen therapy (with
respect to a group of COPD patients not on oxygen
therapy), one study [41] showed a non significant
reduction of dyspnea according to the Borg scale
(4.1 vs. 4.8; ES = 0.5). Significant findings were
reported instead (mean reduction of 3.6 units, ES =
1.8) in emphysematous patients undergoing lung
reduction surgery (iso-work load at incremental
exercise testing) [42].
In general, however, it is known that variations of 2
units with respect to baseline are associated to a
sensation of perceived improvement [43], this being
more evident in patients with a higher baseline resp -
iratory disability.
Visual Analogue Scale (VAS)
First described by Aitken in 1969 [44], the VAS
(Figure 2) found its first field of application in eval-
uating different sensations, and only subsequently
was it applied to determine dyspnea. It is a closed
scale (delimited at its two ends) composed graphi-
cally of a vertical or horizontal line 10 or 20 cm
long and at the two ends of which (often indicated
with dots) correspond two “pictures or verbal
descriptors”, one depicting the maximum intensity
of dyspnea sensation and the other the absence of
perception. 
The choice of verbal descriptors at the two extremes
must take into account the semantic value that
these terms may have for the individual and the
terms thus must be carefully evaluated: e.g. the term
“unbearable” to describe the maximum sensation of
dyspnea could be understood by the patient as
more absolute than the term “maximum”. 
In quantifying dyspnea, the patient is asked to indi-
cate on the VAS the point which corresponds to
his/her own perception, evaluated as the distance
from the zero extreme (non dyspnea) and expressed
as a percentage of the total length of the line. The
VAS is thus an instrument of an analogical type
since the line on which patients mark their refer-
ence point corresponds to the “continuum of dysp-
nea perception”. 
The VAS is economic and easy to use, but the men-
tal operation required of the subject is certainly
complex and calls for a good capacity for abstract
thinking, difficult to achieve at extremes of age. It is
thus of little value applied in children and very eld-
erly subjects. 
Like the Borg scale, the VAS – with a well estab-
lished validity and reliability [1] – is a scale com-
monly used in rehabilitation, especially to measure
dyspnea in response to physical exercise [1]. It is
thus used in numerous studies [24,40,45] as a sub-
jective outcome marker: its value decreases by
approximately 20% compared to baseline in the
cardiopulmonary exercise test, [40,45] while it
decreases by 12% in the 6MWT [24].
In emphysema patients undergoing lung reduction
surgery [42] VAS evaluation of dyspnea at iso-work-
load during CPX has shown a notable reduction of
the individual’s perception of the symptom (on
average from 79.6 to 49.3, with 30.3% variation).
In general, even if few studies have considered the
VAS from the point of view of the MCID as a post-
exercise index of rehabilitation outcome, a mini-
mum variation of 10% is considered indicative of
clinical improvement [43]. 
DYSPNEA MEASUREMENT IN DAILY LIVING
ACTIVITIES 
Dyspnea and muscle fatigue, common symptoms in
respiratory disease patients, often cause interfer-
ence with many occupational activities and in the
disease progression can limit the individual’s partic-
ipation in social and/or recreational activities. In
more advanced phases of the disease, in fact, respi-
ratory patients are not infrequently impaired also in
their ability to perform autonomously personal and
domestic tasks defined as activities of daily living
(ADL).
When “basic activities of daily living” (BADL) are
impaired, the patient needs others to help them ful-
fill their own personal primary care functions: in
severe cases, support is necessary also for elemen-
tary functions such as eating, washing, dressing or
TABLE III: MODIFIED BORG SCALE    
0 (Dyspnea) NONE
0.5 (Dyspnea) EXTREMELY MILD




5 (Dyspnea) RATHER INTENSE
6
7 (Dyspnea) VERY INTENSE
8
9 (Dyspnea) ALMOST UNBEARABLE 
10 (Dyspnea) UNBEARABLE 
From [37], mod.



































0 moving about inside the house. Since promoting
the patient’s autonomy in carrying out ADLs is a pri-
mary goal of PR, the measurement of dyspnea as a
symptom during these very activities is an aspect
that should not be overlooked [46]. 
A “centralized” assessment of the needs and moti-
vations of the individual will thus require both “sub-
jective” analysis (by means of interview or ques-
tionnaire) and “objective” analysis (validated meas-
urement scales capable of precisely assessing the
functional status and the individual’s living environ-
ment). 
Subjective elements of evaluation
Self-evaluation questionnaires enter into this cate-
gory. They give qualitative information about how
the individual perceives their own capacity to cope
with their personal care and domestic care require-
ments, as well as their need for physical and recre-
ational activities.
There exist, however, few valid instruments capable
of measuring in a simple manner the perception
that patients have concerning the effects that their
dyspnea and muscle fatigue have on ADL. Among
the most important are the London Chest Activity of
Daily Living Scale (LCADL) [47], the Pulmonary
Functional Status and Dyspnea Questionnaire
(PFSDQ) [48] and the Oxygen Cost Diagram (OCD)
[49].
The LCADL [47] is a standardized scale, easy to
administer and specific for patients with severe
COPD. The primary goal of this scale is to offer a
measurement of the patient’s ability to carry out
ADLs through an estimation of the level of per-
ceived dyspnea during performance of the investi-
gated activities. The theory on which the instrument
is based is that dyspnea, during the common daily
life activities of the patient, induces a condition of
significant limitation in the individual’s functional
capacity and social participation.
The scale investigates the level of disability induced
by dyspnea associated to 15 common activities,
subdivided into 4 areas (personal care, domestic
activities, physical and social activities) that are
mostly carried out on a daily basis in the home:
recent studies have in fact shown that the LCADL is
a reliable tool for evaluating dyspnea during ADLs
[47,50]. Excluding the part related to domestic
activities, the LCADL has been shown to be useful
in identifying changes in lifestyle (also at follow up)
in patients admitted to a rehabilitation program
[51].
The PFSDQ [48] is a self-completed questionnaire
consisting of 164 questions investigating the indi-
vidual’s functional status and level of dyspnea dur-
ing the performance of activities. It is subdivided
into 6 categories: personal care, mobility, home
management, nutrition, recreational activities and
social activities. Despite the fact it was designed
specifically for use in patients with respiratory dis-
eases, it is not very widely used, perhaps because
many of the questions present are not applicable to
patients with severe disease. Hence, in patients
with very severe COPD a modified, abridged ver-
sion (40 questions only, taking 7 minutes to com-
plete) has been developed and it has shown an
excellent validity, reliability and ease of use [52]. 
The Oxygen Cost Diagram (OCD) [49] is, on the
other hand, a self-evaluation tool designed to pro-
vide an estimate of physical exercise limitation.
Conceptually similar to the VAS, the OCD is
designed as a vertical linear scale 10 cm long with
common ADLs listed on both sides: at the bottom
end of the list are activities with a small oxygen
demand (sleep); as one climbs the list, physical
activities make a progressively growing energy
demand culminating, at the upper end of the scale,
in “walking fast uphill”. Patients are invited to indi-
cate with a line the point corresponding to the phys-
ical task that provokes in them a sensation of dysp-
nea such as to require the suspension of the activity.
The administration of the OCD is very rapid (takes
about 1-2 minutes), and in patients with COPD the
OCD has been found able to distinguish different
levels of disease severity [53]. However, longitudi-
nal studies testing the instrument’s sensitivity with
respect to variations in physical condition have
shown a poor capacity of this scale to detect both
improvement and decline post-rehabilitation
[54,55].
Objective elements of evaluation
Objective instruments useful both in individual
measurement and in monitoring basic functional
capacity during the performance of multiple ADLs
are the BDI/TDI [25] and the Borg scale [37], both,
as described above, widely validated and currently
adopted to assess patients affected by chronic respi-
ratory diseases. The level of physical activity neces-
sary to provoke the sensation of dyspnea is, on the
other hand, the goal of the MRC [22].
As a stimulus to detect dyspnea in ADLs, one may
consider the test of simulation of 4 common ADLs
performed by the upper limbs (putting plates back
on a shelf after washing; simulating window clean-
ing on a blackboard; putting groceries in the cup-
board; changing a light bulb) [56]; this test has
already been reproduced [51] and validated in
COPD patients showing a good correlation with
ventilatory and metabolic responses to convention-
al exercise tests [56]. 
CONCLUSIONS
Dyspnea is a very common and frequent symptom
in chronic respiratory diseases, reported by patients
through specific descriptors and clusters. From the
point of view of an objective estimate of this symp-
tom, it is fundamental to have instruments and
measurement scales that are able to characterize at
baseline patients with different levels of respiratory
disability (MRC, BDI) and observe the evolution in
time (TDI, LCADL). 
In patients undergoing rehabilitation these instru-
ments can moreover perform the function of out-
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Use of the MCID as an instrument for orienting the
significance of the outcome, even if specific to the
measurement scale used, does not yet seem system-
ically reliable as a method to evalutate changes in
dyspnea in this clinical setting, in particular on
account of the limited number of studies and data
available. In our opinion future studies need to
focus on this precise issue. 
CONFLICT OF INTEREST STATEMENT: The authors have no
conflict of interest to declare in relation to the subject of this
manuscript.
  1.  American Thoracic Society. Dyspnea. Mechanisms, assess-
ment, and management: a consensus statement. Am J Respir
Crit Care Med 1999;159:321-340.
  2.  Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N,
Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey
C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais
F, Morgan M, O'Donnell D, Prefault C, Reardon J,
Rochester C, Schols A, Singh S, Troosters T; ATS/ERS
Pulmonary Rehabilitation Writing Committee. American
Thoracic Society/European Respiratory Society Statement
on Pulmonary Rehabilitation. Am J Respir Crit Care Med
2006;173:1390-1413.
  3.  Jones PW, Wilson RC. Cognitive aspects of breathlessness.
In: Adams L, Guz A, eds. Respiratory sensations. New York:
Marcel Dekker, 1996:311-339.
  4.  Simon PM, Schwartzstein RM, Weiss JW, Fencl V,
Teghtsoonian M, Weinberger SE. Distinguishable types of
dyspnea in patients with shortness of breath. Am Rev Respir
Dis 1990;142:1009-1014.
  5.  Elliott MW, Adams L, Cockcroft A, Macrae KD, Murphy K,
Guz A. The language of breathlessness. Use of verbal
descriptors by patients with cardiopulmonary disease. Am
Rev Respir Dis 1991;144:826-832.
  6.  Mahler DA, Harver A, Lentine T, Scott JA, Beck K,
Schwartzstein RM. Descriptors of breathlessness in car-
diorespiratory diseases. Am J Respir Crit Care Med
1996;154:1357-1363.
  7.  Williams M, Cafarella P, Olds T, Petkov J, Frith P. The lan-
guage of breathlessness differentiates between patients with
COPD and age-matched adults. Chest 2008;134:489-496.
  8.  Paintal AS. Vagal sensory receptors and their reflex effects.
Physiol Rev 1973;53:159-227.
  9.  Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan
T, Takishima T. Effects of bronchoconstriction and external
resistive loading on the sensation of dyspnea. J Appl Physiol
1991;71:2183-2190.
10.  Mc Closkey DI. Corollary discharges: motor commands and
perception. In: Brookhart JM, Mouncastle VB, eds: The nerv-
ous system. Handbook of physiology. Bethesda: American
Physiological Society, 1981:2:1415-1447.
11.  Killian KJ, Campbell EJ. Dyspnea. In: C. Roussos, ed. The
Thorax, Part B. New York: Marcel Dekker, 1995:1709-1747.
12.  O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinfla-
tion and exercise intolerance in chronic obstructive pul-
monary disease. Am J Respir Crit Care Med 2001;164:770-
777. 
13.  O’Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative
aspects of exertional breathlessness in chronic airflow limi-
tation: pathophysiologic mechanisms. Am J Respir Crit Care
Med 1997;155:109-115. 
14.  O’Donnell DE, Chau LK, Webb KA. Qualitative aspects of
exertional dyspnea in patients with interstitial lung disease.
J Appl Physiol 1998;84:2000-2009.
15.  O’Donnell DE, Webb KA. Exertional breathlessness in
patients with chronic airflow limitation. The role of lung
hyperinflation. Am Rev Respir Dis 1993;148:1351-1357.
16.  Scano G, Stendardi L, Grazzini M. Understanding dyspnoea
by its language. Eur Respir J 2005;25:380-385.
17.  Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. “Air
hunger” arising from increased PCO2 in mechanically ven-
tilated quadriplegics. Respir Physiol 1989;76:53-67.
18.  Chida M, Inase N, Ichioka M, Miyazato I, Marumo F.
Ratings of perceived exertion in chronic obstructive pul-
monary disease: a possible indicator for exercise training in
patients with this disease. Eur J Appl Physiol Occup Physiol
1991;62:390-393.
19.  Mahler DA, Ward J, Mejia-Alfaro R. Stability of dyspnea rat-
ings after exercise training in patients with COPD. Med Sci
Sports Exerc 2003;35:1083-1087.
20.  Mahler DA, Harver A. A factor analysis of dyspnea ratings,
respiratory muscle strength, and lung function in patients
with chronic obstructive pulmonary disease. Am Rev Respir
Dis 1992;145:467-470. 
21.  Cohen J. Statistical Power Analysis for the Behavioral
Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates,
1988. 
22.  Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The signif-
icance of respiratory symptoms and the diagnosis of chronic
bronchitis in a working population. Br Med J 1959;2:257-
266. 
23.  Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW,
Wedzicha JA. Usefulness of the Medical Research Council
(MRC) dyspnoea scale as a measure of disability in patients
with chronic obstructive pulmonary disease. Thorax
1999;54:581-586.
24.  de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A,
Berger R, Celli B. Power of outcome measurements to
detect clinically significant changes in pulmonary rehabili-
tation of patients with COPD. Chest 2002;121:1092-1098.
25.  Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The
measurement of dyspnea. Contents, interobserver agree-
ment, and physiologic correlates of two new clinical index-
es. Chest 1984;85:751-758.
26.  Guyatt GH, Berman LB, Townsend M, Pugsley SO,
Chambers LW. A measure of quality of life for clinical trials
in chronic lung disease. Thorax 1987;42:773-778.
27.  Mahler DA, Ward J, Fierro-Carrion G, Waterman L, Lentine
TF, Mejia-Alfaro R, Baird JC. Development of self-adminis-
tered versions of modified baseline and transition dyspnea
indexes in COPD. COPD 2004;1:165-172.
28.  Mahler DA, Wells CK. Evaluation of clinical methods for
rating dyspnea. Chest 1988;93:580-586.
29.  Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ,
Townsend M, Jones NL, Pugsley SO. How should we meas-
ure function in patients with chronic heart and lung dis-
ease? J Chronic Dis 1985;38:517-524.
30.  Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L,
Kesten S. Health outcomes following treatment for six
months with once daily tiotropium compared with twice
daily salmeterol in patients with COPD. Thorax
2003;58:399-404.
31.  Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN,
O’Connor GT. Changes in dyspnea, health status, and lung
function in chronic airway disease. Am J Respir Crit Care
Med 1995;151:61-65.































0 transition dyspnoea index in a multinational clinical trial.
Eur Respir J 2003;21:267-272.
33.  Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea
index is a total score of one unit. COPD 2005;2:99-103.
34.  Stevens SS. On the psychophysical law. Psychol Rev
1957;64:153-181.
35.  Borg G. Perceived exertion as an indicator of somatic stress.
Scand J Rehabil Med 1970;2:92-98.
36.  Borg GA. Psychophysical bases of perceived exertion. Med
Sci Sports Exerc 1982;14:377-381.
37.  Mahler DA, Horowitz MB. Perception of breathlessness dur-
ing exercise in patients with respiratory disease. Med Sci
Sports Exerc 1994;26:1078-1081.
38.  Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg
scale measurements of dyspnea during exercise in patients
with COPD. Chest 1995;107:1590-1597.
39.  Stulbarg MS, Carrieri-Kohlman V, Demir-Deviren S, Nguyen
HQ, Adams L, Tsang AH, Duda J, Gold WM, Paul S.
Exercise training improves outcomes of a dyspnea self-man-
agement program. J Cardiopulm Rehab 2002;22:109-121.
40.  Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M,
Ambrosino N. Long-term effectiveness of pulmonary reha-
bilitation in patients with chronic airway obstruction. Eur
Respir J 1999;13:125-132.
41.  Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S,
Whyte K. Ambulatory oxygen improves quality of life of
COPD patients: a randomised controlled study. Eur Respir J
2002;20:306-312.
42.  Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli
BR. Lung-volume reduction improves dyspnea, dynamic
hyperinflation, and respiratory muscle function. Am J Respir
Crit Care Med 1997;155:1984-1990.
43.  Ries AL. Minimally clinically important difference for the
UCSD Shortness of Breath Questionnaire, Borg Scale, and
Visual Analog Scale. COPD 2005;2:105-110.
44.  Aitken RC. Measurement of feelings using visual analogue
scales. Proc R Soc Med 1969;62:989-993. 
 45.  Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack
RL. The effect of comprehensive outpatient pulmonary reha-
bilitation on dyspnea. Chest 1994;105:1046-1052. 
46.  Horne D, Corsello P. Physical and occupational therapy for
patients with chronic lung disease. Semin Respir Med
1993;14:466-481.
47.  Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW.
Development and validation of a standardized measure of
activity of daily living in patients with severe COPD: the
London Chest Activity of Daily Living scale (LCADL). Respir
Med 2000;94:589-596.
48.  Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S, Roos PJ.
Development and testing of the Pulmonary Functional
Status and Dyspnea Questionnaire (PFSDQ). Heart Lung
1994;23:242-250.
49.  McGavin CR., Artvinli M., Naoe H, McHardy GJ.
Dyspnoea, disability, and distance walked: comparison of
estimates of exercise performance in respiratory disease. Br
Med J 1978;2:241-243.
50.  Garrod R, Paul EA, Wedzicha JA. An evaluation of the reli-
ability and sensitivity of the London Chest Activity of Daily
Living Scale (LCADL). Respir Med 2002;96:725-730.
51.  Costi S, Crisafulli E, Antoni FD, Beneventi C, Fabbri LM,
Clini EM. Effects of unsupported upper extremity exercise
training in patients with COPD: a randomized clinical trial.
Chest 2009;136:387-395.
52.  Lareau SC, Meek PM, Roos PJ. Development and testing of
the modified version of the pulmonary functional status and
dyspnea questionnaire (PFSDQ-M). Heart Lung
1998;27:159-168.
53.  O’Brien B, Viramontes JL. Willingness to pay: a valid and
reliable measure of health state preference? Med Decis
Making 1994;14:289-297.
54.  Janssens JP, Breitenstein E, Rochat T, Fitting JW. Does the
’oxygen cost diagram’ reflect changes in six minute walking
distance in follow up studies? Respir Med 1999;93:810-
815.
55.  Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS.
Generic and specific measurement of health-related quality
of life in a clinical trial of respiratory rehabilitation. J Clin
Epidemiol 1999;52:187-192.
56.  Velloso M, Stella SG, Cendon S, Silva AC, Jardim JR.
Metabolic and ventilatory parameters of four activities of
daily living accomplished with arms in COPD patients.
Chest 2003;123:1047-1053.
